The present invention provides a nucleotide having the formula,

Sig-PM-SM-BASE

wherein PM is a phosphate moiety, SM is a sugar moiety and BASE is a pyrimidine, purine or 7-deazapurine moiety. PM is attached to the 3 or the 5 position of the sugar moiety when the nucleotide is a deoxyribonucleotide and at the 2, 3 or 5 position when the nucleotide is a ribonucleotide. BASE is attached to the 1 position of SM from the N1 position when BASE is a pyrmidine or the N9 position when BASE is a purine or 7-deazapurine. Sig is covalently attached to PM directly or via a chemical linkage, and represents a detectable moiety covalently attached to SM directly or through a linkage group. Also provided are an oligo- or polynucleotide comprising at least one such phosphate-moiety labeled nucleotide, and other compositions including those wherein a polypeptide is terminally ligated or attached to the oligo- or polynucleotide. The phosphate-moiety labeled nucleotide, and the oligo- or polynucleotides and other compositions comprising such phosphate-moiety labeled nucleotides, are useful as diagnostic tools for detecting analytes and as therapeutic agents.

 
Web www.patentalert.com

< Recombinant gelatins

< Nucleic acids encoding Eph-like receptor tyrosine kinases

> DNA isolation method

> Method for isolating DNA from biological materials

~ 00234